Addressing Reproductive Coercion in HEalth Settings

Status Completed

Clinical Trial Summary

The primary purpose of this research is to conduct a small matched cluster control trial of an intervention designed to address reproductive coercion and unintended pregnancy (ARCHES - Addressing Reproductive Coercion within Healthcare Settings) adapted to the Kenyan cultural and family planning healthcare context (ARCHES Kenya) so as to provide initial data regarding acceptability, feasibility and efficacy in this high-need LMIC context.

Clinical Trial Description

The project consortium will implement the ARCHES Kenya model across 6 Family Health Options Kenya clinics in Nairobi, Kenya. A matched-pair cluster control design including 600 female family planning (FP) clients ages 15-49 years (inclusive of 360 clients age 15-24 years) will be utilized to evaluate this intervention. Baseline data will be collected prior to routine FP service delivery, with a short exit survey conducted immediately following the clients' FP appointment (ARCHES or standard FP counseling will be provided during this visit). Follow-up data will be collected at 3 and 6-months post-intervention. Qualitative data will be collected from intervention providers (n=12) regarding implementation via weekly technical assistance sessions during the first three months, and then monthly, regarding acceptability and feasibility of integrating ARCHES into routine FP counseling, including barriers and facilitators to implementation, and any issues with maintaining fidelity to the ARCHES model. Structured interviews with select providers (n=12) will also be conducted at 3-months post-training to delve further into these issues. Structured interviews with intervention participants reporting experience of RC in the past 3 months on the baseline survey (20 participants ages 15-24, 15 ages 25-49; total n=35) will be conducted at 3-months follow-up to assess their experience of the intervention; perceived utility of the messages, care and materials; barriers to utilizing messaging and materials; and suggestions for improvement. Analyses specific to participants ages 15-24 will provide findings to guide consideration of ARCHES as an effective strategy to improve reproductive health and reduce GBV among adolescents in the region. The project consortium will engage Government of Kenya officials, IPPF executive directors and IPPF member associations across the federation to pave the way for the future roll out of this approach in other low and middle-income country (LMIC) contexts. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03534401
Study type	Interventional
Source	University of California, San Diego
Contact
Status	Completed
Phase	N/A
Start date	June 1, 2018
Completion date	December 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00928538` - Nurse Family Partnership (NFP) Contraceptive Study	Phase 4
Not yet recruiting	`NCT04521517` - Effect of Pamphlet Supported Counseling During Child Immunization on the Initiation of Post-partum Family Planning	N/A
Completed	`NCT03660514` - Jovenes Sanos: Preventing IPV and RC	N/A
Completed	`NCT02866643` - Labor and Delivery Implant Insertion: A Randomized Controlled Trial	Phase 3
Completed	`NCT05503992` - Evaluating the Efficacy of Using a Digital Consumption Management Tool for Family Planning in Zambia	N/A
Recruiting	`NCT04558229` - RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users	Phase 4
Completed	`NCT03973593` - Evaluation of Dynamics of Contraceptive Use, Discontinuation and Method Switching in Migori and Kitui Counties, Kenya
Completed	`NCT02714231` - Oral Diclofenac Sodium Versus Oral Hyoscine Butyl Bromide During Intrauterine Device Insertion	Phase 4
Completed	`NCT02711358` - Indomethacin Use in Pain Relief During Intrauterine Device Insertion	Phase 4
Completed	`NCT01593943` - Gender Equity-Focused, Male-Centered Family Planning for Rural India	Phase 3
Completed	`NCT03106727` - Evaluating the Impact of a Community Health Worker Program in Neno, Malawi	N/A
Completed	`NCT01288274` - Community Based Distribution of Injectable Contraceptives in Tigray, Ethiopia	N/A
Completed	`NCT03576157` - Kilkari Impact Evaluation	N/A
Not yet recruiting	`NCT04970420` - Health Responsibility and Family Planning ın Immigrant Women (Ahıska Turks).	N/A
Completed	`NCT01894126` - Mobile Phone Messaging to Improve Women's and Children's Health (Mobile WACh) in Kenya	N/A
Completed	`NCT03490617` - Misoprostol Prior to IUD Insertion in Nullipara	Phase 3
Completed	`NCT06320964` - The TARANG Intervention	N/A
Completed	`NCT03135288` - Cell-phone Assisted Postpartum Counseling on the Use of Long-acting Reversible Contraceptives	N/A
Completed	`NCT02633631` - Contraceptive Choice Center
Recruiting	`NCT05838859` - Contraception and Mental Health: Are we Doing Enough?

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Addressing Reproductive Coercion in HEalth Settings - Kenya — ARCHES

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms